For a selelct group of patients undergoing interventional procedures or cardiac surgery, the risk of acute renal failure, caused by the body's inability to flush out high doses of contrast agents, represents a major, and potentially life-threatening complication. FlowMedica hopes to make prevention and treatment of acute renal failure a standard of care with an innovative technology that links drug and device therapies.
By David Cassak
Over the past decade or so, the clinical imperialism—if that's not too strong a word—of interventional cardiology has been nothing...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
